4.0
26 May 2026
Current employee, more than 3 years
East Hanover, NJ
Recommend
CEO approval
Business outlook
Pros
Overall, very good work-life balance and comparable benefits across industry. My function was great! Career advancement opportunities are limited.
Cons
RSUs and options are given to people at senior principal scientist level and above. Anyone below that is not getting it. Comes across as very stingy company and try to pinch pennies now and then while allocating 15 billion dollar for shareholder returns to Wall Street. Their risk-taking appetite is less compared to more nimble upcomig biotechs.